Business Context and Reporting Period
This Form 8-K is a current report filed by Trxade Group, Inc. (trading symbol: MEDS) on May 4, 2020. The filing serves to announce the company's financial results for the three-month period ended March 31, 2020. The registrant is an emerging growth company incorporated in Delaware with principal executive offices in Land O' Lakes, Florida.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the body of this Form 8-K.
Material Changes
The document does not detail specific material changes versus prior periods. It solely references the issuance of a press release containing the summary of financial results for the quarter ended March 31, 2020.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The referenced press release contains forward-looking statements regarding future financial performance, events, and trends. These are subject to known and unknown risks, uncertainties, and assumptions.
- Risk Factors: The filing explicitly warns that actual results may differ materially from projected statements. Risks are detailed in the "Risk Factors" and "Management's Discussion and Analysis" sections of the company's periodic filings (Form 10-Q and Form 10-K).
- Update Obligation: The company states it undertakes no obligation to publicly update or revise forward-looking statements after the date of this filing, except as required by law.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 4, 2020) for specific revenue, net income, and cash flow figures for the quarter ended March 31, 2020.
- Verify the company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.
- Consult the most recent Form 10-Q and Form 10-K filings on the SEC website or the company's investor relations page for detailed risk factors and management commentary.
- Confirm the trading symbol MEDS on the NASDAQ Capital Market.